[Management of hematologic malignancies during pregnancy].
Hodgkin's disease, non-Hodgkin lymphoma or leukemia occurring in a pregnant patient is a rare event. Diagnosis of hematologic malignancies in a pregnant woman usually poses a quandrum of psychological, ethical and medical considerations. All of these situations require a multidisciplinary team. Adequate staging and treatment of hematologic malignancies are complicated by the pregnancy. In the first trimester, termination of the pregnancy should be considered in order to provide the best outcome for the woman and fetus. In this review we have focused on the use of chemotherapy for the pregnant patient. This review reveals that the use of chemotherapy resulted in both objective disease remissions and the subsequent delivery of normal infant.
Maloisel
F
F
Service d'Onco-Hématologie, Hôpitaux Universitaires de Strasbourg, Hôpital de Hautepierre, Strasbourg.
Dreyfus
M
M
Neuhart
D
D
Ritter
J
J
Oberling
F
F
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007938:Leukemia / Q000175:diagnosis / Q000188:drug therapy*; D008223:Lymphoma / Q000175:diagnosis / Q000188:drug therapy*; D008431:Maternal-Fetal Exchange; D009367:Neoplasm Staging; D010348:Patient Care Team; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000175:diagnosis / Q000188:drug therapy*; D011256:Pregnancy Outcome; D016896:Treatment Outcome
Prise en charge des hémopathies malignes survenant au cours de la grossesse.